BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/10/2026 10:31:34 AM | Browse: 13 | Download: 0
| Category |
Obstetrics & Gynecology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Clinical model predicting recurrence after fertility-sparing treatment for endometrial cancer and atypical hyperplasia: Development and external validation
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ze-Rui Xiao, Si-Cheng Shen, Lin-Lin Bo, Si-Jia Liu, Yi-Fan Feng, Zhuo-Yu Zhai, Jin Lai, Xiao-Tong Feng, Si-Ru Liu, Xue-Zhen Luo, Jian-Liu Wang, Xing-Chen Li and Yi-Qin Wang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 82501962 |
| Key Project of the National Natural Science Foundation of China |
No. 82230050 |
| Major Projects of National Science and Technology |
No. 2025ZD0545900 |
| Research and Development Fund of Peking University People’s Hospital |
No. RDEB2024-10 |
| Major Projects of National Science and Technology |
No. 2025ZD0545902 |
|
| Corresponding Author |
Yi-Qin Wang, Department of Obstetrics and Gynecology, Peking University People’s Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, China. emily_wang92@163.com |
| Key Words |
Endometrial cancer; Atypical endometrial hyperplasia; Fertility-sparing treatment; Recurrence prediction; Risk score |
| Core Tip |
This study developed and externally validated a five-factor model for recurrence-risk stratification after complete remission following fertility-sparing treatment in patients with stage IA endometrial cancer or atypical endometrial hyperplasia. The model demonstrated moderate discriminatory ability in the development and external validation cohorts. It may assist recurrence-risk stratification and individualized follow-up, although further prospective multicenter validation and calibration are warranted before clinical implementation. |
| Citation |
Xiao ZR, Shen SC, Bo LL, Liu SJ, Feng YF, Zhai ZY, Lai J, Feng XT, Liu SR, Luo XZ, Wang JL, Li XC, Wang YQ. Clinical model predicting recurrence after fertility-sparing treatment for endometrial cancer and atypical hyperplasia: Development and external validation. World J Clin Oncol 2026; In press
|
 |
Received |
|
2026-08-27 07:49 |
|
Peer-Review Started |
|
2026-08-27 07:49 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2026-09-04 02:06 |
|
Revised |
|
2026-09-27 12:39 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-11-10 03:02 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-11-10 10:31 |
|
Articles in Press |
|
2026-11-10 10:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
|
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
